Detalhe da pesquisa
1.
Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study.
Liver Int
; 36(4): 505-14, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26519669
2.
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.
Liver Int
; 35(1): 108-19, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24517252
3.
Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection.
Gastroenterology
; 145(4): 790-800.e3, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23811112
4.
IL-12 administration leads to a transient depletion of T cells, B cells, and APCs and concomitant abrogation of the HLA-A2.1-restricted CTL response in transgenic mice.
J Immunol
; 169(1): 63-7, 2002 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12077229
5.
Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial.
Am J Gastroenterol
; 99(7): 1298-305, 2004 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15233669